A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME

NCT06708260 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema (DME)

Interventions

DRUG: ENN0403, low dose
DRUG: ENN0403, high dose

Sponsor

EnnovaBio